↓ Skip to main content

Dove Medical Press

Article Metrics

Associations between body mass index and molecular subtypes as well as other clinical characteristics of breast cancer in Chinese women

Overview of attention for article published in Therapeutics and Clinical Risk Management, March 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
12 Mendeley
Title
Associations between body mass index and molecular subtypes as well as other clinical characteristics of breast cancer in Chinese women
Published in
Therapeutics and Clinical Risk Management, March 2013
DOI 10.2147/tcrm.s41203
Pubmed ID
Authors

Li-Li Tang, Chen, Ou, Wang, Wu, Yan

Abstract

Several studies have shown a positive association between body mass index (BMI) and the development of hormone receptor-positive breast cancer in postmenopausal women; however, the associations between BMI groups and molecular subtypes have yet to be well defined in premenopausal breast cancer patients.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 8%
Colombia 1 8%
Unknown 10 83%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 25%
Student > Ph. D. Student 2 17%
Researcher 2 17%
Student > Master 2 17%
Student > Postgraduate 1 8%
Other 2 17%
Readers by discipline Count As %
Unspecified 5 42%
Medicine and Dentistry 3 25%
Mathematics 1 8%
Nursing and Health Professions 1 8%
Economics, Econometrics and Finance 1 8%
Other 1 8%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2013.
All research outputs
#2,931,421
of 6,239,510 outputs
Outputs from Therapeutics and Clinical Risk Management
#409
of 591 outputs
Outputs of similar age
#48,556
of 98,473 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#8
of 13 outputs
Altmetric has tracked 6,239,510 research outputs across all sources so far. This one is in the 29th percentile – i.e., 29% of other outputs scored the same or lower than it.
So far Altmetric has tracked 591 research outputs from this source. They receive a mean Attention Score of 3.4. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 98,473 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.